Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Haystack Oncology is built upon two decades of expertise in liquid biopsy technology and clinical development, spearheaded by scientists specializing in cancer genomics. These pioneers envisioned non-invasive cancer screening, minimal residual disease (MRD) detection, and advanced disease therapy monitoring. The impact of their discoveries has been transformative, positively influencing the lives of millions. Furthermore, comp...
Haystack Oncology is built upon two decades of expertise in liquid biopsy technology and clinical development, spearheaded by scientists specializing in cancer genomics. These pioneers envisioned non-invasive cancer screening, minimal residual disease (MRD) detection, and advanced disease therapy monitoring. The impact of their discoveries has been transformative, positively influencing the lives of millions. Furthermore, companies leveraging their technology have collectively generated billions of dollars in enterprise value.

List your booth number for exhibitions, ask us